APOLLO MEDICAL HOLDINGS INC (AMEH) Fundamental Analysis & Valuation

NASDAQ:AMEH • US03763A2078

Current stock price

40.82 USD
-0.88 (-2.11%)
At close:
40.82 USD
0 (0%)
After Hours:

This AMEH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. AMEH Profitability Analysis

1.1 Basic Checks

  • In the past year AMEH was profitable.
  • AMEH had a positive operating cash flow in the past year.
AMEH Yearly Net Income VS EBIT VS OCF VS FCFAMEH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M 40M 60M 80M 100M

1.2 Ratios

  • AMEH's Return On Assets of 4.27% is fine compared to the rest of the industry. AMEH outperforms 74.58% of its industry peers.
  • With a decent Return On Equity value of 7.71%, AMEH is doing good in the industry, outperforming 71.19% of the companies in the same industry.
  • AMEH has a Return On Invested Capital of 7.06%. This is in the better half of the industry: AMEH outperforms 75.42% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AMEH is in line with the industry average of 8.43%.
Industry RankSector Rank
ROA 4.27%
ROE 7.71%
ROIC 7.06%
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
AMEH Yearly ROA, ROE, ROICAMEH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 500 1K 1.5K 2K

1.3 Margins

  • The Profit Margin of AMEH (3.45%) is better than 75.42% of its industry peers.
  • In the last couple of years the Profit Margin of AMEH has grown nicely.
  • AMEH has a better Operating Margin (7.61%) than 77.97% of its industry peers.
  • In the last couple of years the Operating Margin of AMEH has grown nicely.
  • AMEH has a worse Gross Margin (16.34%) than 70.34% of its industry peers.
  • AMEH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.61%
PM (TTM) 3.45%
GM 16.34%
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
AMEH Yearly Profit, Operating, Gross MarginsAMEH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20 -20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. AMEH Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMEH is destroying value.
  • Compared to 1 year ago, AMEH has more shares outstanding
  • The debt/assets ratio for AMEH has been reduced compared to a year ago.
AMEH Yearly Shares OutstandingAMEH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
AMEH Yearly Total Debt VS Total AssetsAMEH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

2.2 Solvency

  • AMEH has an Altman-Z score of 4.53. This indicates that AMEH is financially healthy and has little risk of bankruptcy at the moment.
  • AMEH's Altman-Z score of 4.53 is amongst the best of the industry. AMEH outperforms 83.90% of its industry peers.
  • The Debt to FCF ratio of AMEH is 1.89, which is an excellent value as it means it would take AMEH, only 1.89 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of AMEH (1.89) is better than 85.59% of its industry peers.
  • A Debt/Equity ratio of 0.35 indicates that AMEH is not too dependend on debt financing.
  • AMEH's Debt to Equity ratio of 0.35 is fine compared to the rest of the industry. AMEH outperforms 65.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.89
Altman-Z 4.53
ROIC/WACC0.85
WACC8.27%
AMEH Yearly LT Debt VS Equity VS FCFAMEH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 2.35 indicates that AMEH has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.35, AMEH is doing good in the industry, outperforming 79.66% of the companies in the same industry.
  • AMEH has a Quick Ratio of 2.35. This indicates that AMEH is financially healthy and has no problem in meeting its short term obligations.
  • AMEH has a better Quick ratio (2.35) than 81.36% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
AMEH Yearly Current Assets VS Current LiabilitesAMEH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. AMEH Growth Analysis

3.1 Past

  • AMEH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.58%.
  • AMEH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.03% yearly.
  • The Revenue has grown by 27.05% in the past year. This is a very strong growth!
  • The Revenue has been growing by 81.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.59% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 26.59% on average over the next years. This is a very strong growth
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AMEH Yearly Revenue VS EstimatesAMEH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
AMEH Yearly EPS VS EstimatesAMEH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. AMEH Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 40.82, AMEH can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of AMEH indicates a somewhat cheap valuation: AMEH is cheaper than 60.17% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.42. AMEH is valued slightly more expensive when compared to this.
  • The Price/Forward Earnings ratio is 28.34, which means the current valuation is very expensive for AMEH.
  • Based on the Price/Forward Earnings ratio, AMEH is valued a bit cheaper than 62.71% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.29, AMEH is valued a bit more expensive.
Industry RankSector Rank
PE 40.82
Fwd PE 28.34
AMEH Price Earnings VS Forward Price EarningsAMEH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • AMEH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AMEH is cheaper than 61.86% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMEH indicates a somewhat cheap valuation: AMEH is cheaper than 73.73% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.06
EV/EBITDA 15.55
AMEH Per share dataAMEH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • AMEH's earnings are expected to grow with 15.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.64
PEG (5Y)N/A
EPS Next 2Y16.56%
EPS Next 3Y15.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AMEH Dividend Analysis

5.1 Amount

  • AMEH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

AMEH Fundamentals: All Metrics, Ratios and Statistics

APOLLO MEDICAL HOLDINGS INC

NASDAQ:AMEH (2/23/2024, 8:00:00 PM)

After market: 40.82 0 (0%)

40.82

-0.88 (-2.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07
Earnings (Next)02-27
Inst Owners53.14%
Inst Owner Change-1.62%
Ins Owners21.32%
Ins Owner Change0%
Market Cap1.90B
Revenue(TTM)1.33B
Net Income(TTM)45.80M
Analysts83.33
Price Target47.49 (16.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.31
Dividend Growth(5Y)N/A
DP7.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.72%
Min EPS beat(2)9.8%
Max EPS beat(2)39.63%
EPS beat(4)3
Avg EPS beat(4)20.8%
Min EPS beat(4)-0.9%
Max EPS beat(4)39.63%
EPS beat(8)6
Avg EPS beat(8)22.78%
EPS beat(12)10
Avg EPS beat(12)32.72%
EPS beat(16)12
Avg EPS beat(16)-118.74%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.17%
Revenue beat(4)2
Avg Revenue beat(4)4.65%
Min Revenue beat(4)-2.49%
Max Revenue beat(4)17.32%
Revenue beat(8)6
Avg Revenue beat(8)8.34%
Revenue beat(12)10
Avg Revenue beat(12)8.2%
Revenue beat(16)12
Avg Revenue beat(16)7.16%
PT rev (1m)4.22%
PT rev (3m)-6.25%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)7.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.34%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 40.82
Fwd PE 28.34
P/S 1.43
P/FCF 17.06
P/OCF 14.21
P/B 3.2
P/tB 7.79
EV/EBITDA 15.55
EPS(TTM)1
EY2.45%
EPS(NY)1.44
Fwd EY3.53%
FCF(TTM)2.39
FCFY5.86%
OCF(TTM)2.87
OCFY7.04%
SpS28.49
BVpS12.74
TBVpS5.24
PEG (NY)2.64
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 4.27%
ROE 7.71%
ROCE 11.61%
ROIC 7.06%
ROICexc 10.35%
ROICexgc 25.21%
OM 7.61%
PM (TTM) 3.45%
GM 16.34%
FCFM 8.4%
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
ROICexc(3y)12.15%
ROICexc(5y)11.69%
ROICexgc(3y)43.38%
ROICexgc(5y)51.37%
ROCE(3y)12.51%
ROCE(5y)12.79%
ROICexgc growth 3Y1.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.67%
ROICexc growth 5YN/A
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
F-Score6
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.89
Debt/EBITDA 1.76
Cap/Depr 132.23%
Cap/Sales 1.68%
Interest Coverage 8.45
Cash Conversion 113.54%
Profit Quality 243.47%
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 4.53
F-Score6
WACC8.27%
ROIC/WACC0.85
Cap/Depr(3y)82.27%
Cap/Depr(5y)51.68%
Cap/Sales(3y)1.55%
Cap/Sales(5y)1.01%
Profit Quality(3y)102.9%
Profit Quality(5y)124.71%
High Growth Momentum
Growth
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A
EBIT growth 1Y7.56%
EBIT growth 3Y44.74%
EBIT growth 5YN/A
EBIT Next Year55.45%
EBIT Next 3Y28.75%
EBIT Next 5YN/A
FCF growth 1Y77.28%
FCF growth 3Y67.35%
FCF growth 5YN/A
OCF growth 1Y67.48%
OCF growth 3Y81.79%
OCF growth 5YN/A

APOLLO MEDICAL HOLDINGS INC / AMEH Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for APOLLO MEDICAL HOLDINGS INC?

ChartMill assigns a fundamental rating of 6 / 10 to AMEH.


What is the valuation status of APOLLO MEDICAL HOLDINGS INC (AMEH) stock?

ChartMill assigns a valuation rating of 3 / 10 to APOLLO MEDICAL HOLDINGS INC (AMEH). This can be considered as Overvalued.


How profitable is APOLLO MEDICAL HOLDINGS INC (AMEH) stock?

APOLLO MEDICAL HOLDINGS INC (AMEH) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for AMEH stock?

The Price/Earnings (PE) ratio for APOLLO MEDICAL HOLDINGS INC (AMEH) is 40.82 and the Price/Book (PB) ratio is 3.2.


How financially healthy is APOLLO MEDICAL HOLDINGS INC?

The financial health rating of APOLLO MEDICAL HOLDINGS INC (AMEH) is 8 / 10.